Clinical Trials Logo

Clinical Trial Summary

The combination of anti-platelet medicine treatment and Chinese traditional medicine (TCM) promoting blood circulation to removing blood stasis is widely used in treatment for cardiovascular disease. However, the material foundation, effective mechanism and drug-drug interaction is still not clear. In order to solve the puzzle of rational use of Joint application by TCM and Western Medicine(WM),investigators conduct a research on mechanism of drug-drug interaction between salvianolate injection and aspirin based on metabolic enzyme and PK-PD model. This clinical trial contain three groups, aspirin group, salvianolate injection group and combination (salvianolate injection+aspirin) group. Investigators collect blood samples at special time points during post-administration.Investigators have already find out the Salvianolate's pharmacokinetic characteristics in vivo and establish the biological sample-testing analysis method in previous research. Depending on these results, this clinical trial aim to explore the pharmacodynamics-pharmacokinetics(PK-PD) characteristics of combination with Salvianolate and aspirin through biomarkers, blood concentration. Finally clarify the TCM and WM material basis and mutual mechanism of drug interaction and guide reasonable clinical prescription.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03306550
Study type Interventional
Source Xiyuan Hospital of China Academy of Chinese Medical Sciences
Contact Rui Li, MD,Phd
Phone 0086+01062835651
Email crystal005@163.com
Status Not yet recruiting
Phase N/A
Start date October 10, 2017
Completion date October 10, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Recruiting NCT02870764 - The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris Phase 4
Completed NCT04648306 - Restore EF Observational Study
Recruiting NCT05933083 - MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation N/A
Not yet recruiting NCT02280850 - Efficacy and Safety Study of Guanxin Shutong Capsule to Treat Chronic Stable Angina Phase 4
Completed NCT04785846 - Registry of RESOLUTE-ONYX™ Zotarolimus-eluting Stent Utilization in Percutaneous Small Vessel Coronary Interventionism.
Completed NCT03759067 - Method of Clopidogrel Pre-treatment Undergoing Conventional Coronary Angiogram in Angina Patients N/A
Completed NCT03193294 - CORonary MICrovascular Angina (CorMicA) N/A
Completed NCT04131816 - HeartHome: A Nurse-Driven, Home-Based Cardiac Rehabilitation Program N/A
Recruiting NCT06075602 - COMPLEX Registry - A Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting With compLEX and Calcified Coronary Artery Disease
Recruiting NCT03783351 - Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE) N/A
Recruiting NCT06464042 - Influence of Air Quality on the Development and Progression of Premature Coronary Artery Disease
Not yet recruiting NCT05857904 - Clinical Outcomes of CT-FFR Versus QFR-guided Strategy for Decision-Making in Patients With Stable Chest Pain N/A
Recruiting NCT01838148 - Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia
Terminated NCT02914834 - Acupuncture for Individuals With Stable Angina N/A
Recruiting NCT05825339 - Absolute Flow for Ischemia With No Obstructive Coronary Arteries
Completed NCT05804500 - RecoveryPlus Telerehab Platform Pilot Study N/A
Completed NCT03518645 - Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds N/A
Terminated NCT01550614 - Efficacy and Safety of Ad5FGF-4 for Myocardial Ischemia in Patients With Stable Angina Due to Coronary Artery Disease Phase 3
Recruiting NCT05056662 - Post-Revascularization Optimization and PHysiological Evaluation of intermediaTe Lesions